Details of the Drug
General Information of Drug (ID: DMY59KQ)
| Drug Name |
Nitracrine
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
4533-39-5; Nitracrine [INN]; Nitracrinum [INN-Latin]; Nitracrina [INN-Spanish]; UNII-712MLZ30SB; CCRIS 1973; 712MLZ30SB; 1-Nitro-9-(dimethylaminopropylamino)acridine; C18H20N4O2; 1-Nitro-9-(3'-dimethylaminopropylamino)-acridine; 9-((3-(Dimethylamino)propyl)amino)-1-nitroacridine; Nitracrinum; Nitracrina; N',N'-dimethyl-N-(1-nitroacridin-9-yl)propane-1,3-diamine; ACRIDINE, 9-(3-(DIMETHYLAMINO)PROPYLAMINO)-1-NITRO-; 1,3-Propanediamine, N,N-dimethyl-N'-
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 324.4 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 3.7 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 5 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 5 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


